David A Frank

12PUBLICATIONS
72CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsHaematological tumoursMolecular targetsCancer cell biologyMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 17, 2025
Challenging the "Undruggable"─Targeting STAT3 but Identifying Potent TrkA-Targeted Inhibitors.

Petar Iliev, Conall McCutcheon, Tizita H Admas

|Aug 07, 2024
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.

Michael J Hochman, David A Frank

|Apr 13, 2024
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.

Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad

|Feb 25, 2023
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity.

Jennifer I Brown, Peng Wang, Alan Y L Wong

|Dec 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.

Evan C Chen, Helen Gandler, Isidora Tošić

|Nov 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.

Laura E Stevens, Guillermo Peluffo, Xintao Qiu

Pageof 2